Medicare prescription drug cost, prescriptions and prescribers, 2024
Medicare cost, 2024
$35.6M
-5.8% from 2023
Prescriptions
3,040
$11,697.83 per claim
Patients
279
297 prescribers
Total spending, 2024
$35.6M
$127,469.30 per patient
Medicare prescription drug plans paid $35.6M for Aralast Np in 2024, for 3,040 prescriptions and refills to 279 patients (down 5.8% from 2023). The average cost per claim was $11,697.83.
Missouri had the highest Medicare cost for Aralast Np in 2024: $2.7M for 226 claims, followed by New York ($2.0M).
Humam W Farah, pulmonary disease in Hannibal, MO, had the highest Medicare cost for Aralast Np in 2024: 36 claims costing $637K.
Aralast Np is made by Takeda Pharmaceutical Company Limited (TAK), listed in the Medicare spending data as Baxalta US Inc..
All plans and makers
Where the prescribers practice, 2024
By Medicare drug cost
| Prescriber | Type | Claims | Patients | Cost |
|---|---|---|---|---|
| Humam W Farah Hannibal, MO | Pulmonary Disease | 36 | Under 11 | $637K |
| David O Nyanjom Columbia, MD | Pulmonary Disease | 40 | Under 11 | $396K |
| Douglas Hogarth |
| Year | Prescribers | Claims | Patients | Cost |
|---|---|---|---|---|
| 2022 | 343 | 3,891 | 336 | $41.8M |
| 2023 | 304 | 3,360 | 285 | $37.7M |
| 2024 | 297 | 3,040 | 279 | $35.6M |
More drugs: top Medicare drugs by cost and the Prescriptions tab.
Official US government data on Medicare prescription drug plans (Part D) and Medicaid drug use. Cost and spending are before the rebates drug makers pay. Prescribers with fewer than 11 claims of the drug are not published.
| Pulmonary Disease |
| 28 |
| Under 11 |
| $383K |
| Kayla Halleron Golden Valley, MN | Physician Assistant | 26 | Under 11 | $376K |
| John G Southard Council Bluffs, IA | Pulmonary Disease | 13 | Under 11 | $349K |
| Charlton B Strange Charleston, SC | Pulmonary Disease | 17 | Under 11 | $340K |
| Thomas R Hinson Jr. Winston Salem, NC | Pulmonary Disease | 13 | Under 11 | $319K |
| Robert G Shellman Shelbyville, IN | Pulmonary Disease | 18 | Under 11 | $310K |
| Michael J Ellison Santa Cruz, CA | Pulmonary Disease | 14 | Under 11 | $305K |
| Daniel L Holt Washington, PA | Family Practice | 32 | Under 11 | $300K |
| Edward Eden New York, NY | Pulmonary Disease | 24 | Under 11 | $287K |
| CHI Jane Ellison Greensboro, NC | Internal Medicine | 13 | Under 11 | $285K |
| Joshua N Aaron Elkton, MD | Pulmonary Disease | 25 | Under 11 | $276K |
| Joseph W Auxier Fremont, NE | Pulmonary Disease | 13 | Under 11 | $274K |
| Daniel R Woolery Sedalia, MO | Critical Care (Intensivists) | 26 | Under 11 | $257K |
| Sallustio Delre Somers Point, NJ | Pulmonary Disease | 13 | Under 11 | $246K |
| Sami S Jawad Rockingham, VA | Pulmonary Disease | 14 | Under 11 | $243K |
| Ryan J Bohle Fort Wayne, IN | Pulmonary Disease | 13 | Under 11 | $243K |
| Ronald A Zielinski Bay Shore, NY | Pulmonary Disease | 12 | Under 11 | $237K |
| Hanan Khadam-Makhoul Little Rock, AR | Pulmonary Disease | 14 | Under 11 | $235K |
| Terrence D Coulter Springfield, MO | Pulmonary Disease | 13 | Under 11 | $231K |
| Philip M Detrana Sheboygan, WI | Pulmonary Disease | 12 | Under 11 | $226K |
| James Witten Jr. Salem, VA | Pulmonary Disease | 14 | Under 11 | $223K |
| Whitney Barton Corbin, KY | Nurse Practitioner | 24 | Under 11 | $218K |
| Kerri Schey Green Bay, WI | Nurse Practitioner | 13 | Under 11 | $215K |
Spending by manufacturer as listed in the spending data
| Manufacturer | Claims | Spending |
|---|---|---|
| Baxalta US Inc. TAK | 3,041 | $35.6M |